Publikationen 2021

1. Millischer M, Heinzl M, Faka A, Resl M, Trepci A, Klammer C, Egger M, Dieplinger B, Clodi M, Schwieler L. Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial. J Neuroinflammation 2021 [PubMed]

2. Robier C, Hoefler G, Egger M. Simultaneous occurrence of EDTA-dependent lymphoagglutination and agglutination of myeloid cells in a patient with chronic myelomonocytic leukemia. Clin Chem Lab Med 2021 [PubMed]

3. Klausberger M, Duerkop M, Haslacher H, Wozniak-Knopp G, Cserjan-Puschmann M, Perkmann T, Lingg N, Aguilar PP, Laurent E, De Vos J, Hofner M, Holzer B, Stadler M, Manhart G, Vierlinger K, Egger M, Milchram L, Gludovacz E, Marx N, Köppl C, Tauer C, Beck J, Maresch D, Grünwald-Gruber C, Strobl F, Satzer P, Stadlmayr G, Vavra U, Huber J, Wahrmann M, Eskandary F, Breyer MK, Sieghart D, Quehenberger P, Leitner G, Strassl R, Egger AE, Irsara C, Griesmacher A, Hoermann G, Weiss G, Bellmann-Weiler R, Loeffler-Ragg J, Borth N, Strasser R, Jungbauer A, Hahn R, Mairhofer J, Hartmann B, Binder NB, Striedner G, Mach L, Weinhäusel A, Dieplinger B, Grebien F, Gerner W, Binder CJ, Grabherr R. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine 2021 Apr 24;67:103348 [PubMed]

4. Robier C, Knaus G, Egger M. Acquired Pelger-Huet anomaly in two patients with chronic lymphocytic leukemia treated with venetoclax. Clin Chem Lab Med 2021 [PubMed]

5. Resl M, Heinzl MW, Klammer C, Egger M, Feldbauer R, Pohlhammer J, Dieplinger B, Clodi M. Storm of Cardiovascular Markers After LPS Administration in Human Volunteers. J Cardiovasc Transl Res 2021 [PubMed]

6. Egger M, Bundschuh C, Wiesinger K, Bräutigam E, Berger T, Clodi M, Dieplinger B. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria. Clin Chem Lab Med 2021;59:e231-4. [PubMed]